Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV

Vaccine. 2011 Oct 19;29(45):7876-7. doi: 10.1016/j.vaccine.2011.08.066. Epub 2011 Aug 26.

Abstract

Clinical experience suggests Oculorespiratory Syndrome (ORS) following influenza vaccination is rare in HIV but this is not well evaluated. We assessed ORS incidence in a randomized influenza vaccine trial of HIV participants. The overall incidence was 0.8% suggesting that influenza vaccine ORS incidence is reduced in HIV.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Eye Diseases / chemically induced*
  • Eye Diseases / epidemiology*
  • Eye Diseases / immunology
  • Female
  • HIV Infections / immunology*
  • Humans
  • Incidence
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / adverse effects*
  • Male
  • Middle Aged
  • Respiratory Tract Diseases / chemically induced*
  • Respiratory Tract Diseases / epidemiology*
  • Respiratory Tract Diseases / immunology
  • Young Adult

Substances

  • Influenza Vaccines